Ceevra 3D Models Improve Outcomes for Patients Undergoing Prostate Cancer Surgery

In a multisite randomized controlled trial published in JAMA Network Open in September 2024, the use of Ceevra 3D models in robotic prostatectomy procedures were shown to reduce risk of cancer recurrence, improve functional outcomes, and improve rates of trifecta outcomes.

New Combined Therapy Helps Extend Lives of Men With Prostate Cancer

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.

New device helps restore penile length and sexual function after prostate cancer surgery

A new type of penile traction therapy (PTT) device can increase penile length and preserve erectile function in men who have undergone prostate cancer surgery (prostatectomy), reports a clinical trial in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Post-Surgical Pain Relief Without Opioids

Clinician researchers at the University of Miami Miller School of Medicine have shown that patients don’t necessarily need opioids for pain relief following robotic prostatectomies. In a study published in the Journal of Robotic Surgery, the team found that strategic use of local anesthetic and non-steroidal anti-inflammatory drugs (NSAIDs) plus acetaminophen can effectively control post-surgical pain without narcotics.

Ocean Medical Center Names Mina M. Fam, M.D., Medical Director of Robotics Surgery Program

Hackensack Meridian Ocean Medical Center is pleased to announce that Mina M. Fam, M.D., MBA, has been named medical director of the Center for Robotic Surgery. Dr. Fam is board certified in urology and is fellowship trained in urologic oncology. He specializes in all aspects of urologic cancer and robotic surgery offering the most advanced procedures for urologic cancers including prostate, kidney, and bladder cancers, adrenalectomy and nephrectomy, prostatectomy and urinary obstruction.

Surgery Milestone Reached for Rutgers Cancer Institute Urologic Oncology Leader at Robert Wood Johnson University Hospital

Rutgers Cancer Institute of New Jersey Urologic Oncology chief marks a major milestone in completing his 2,000th robotic prostatectomy at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility and one of the few hospitals in the state designated to teach surgeons about this technique.